LeadIQ logo
Learn more at LeadIQ.com

Insights

Financial Growth Potential Arsenal Biosciences, Inc. has shown significant financial growth potential with reported revenues between $10M - $50M and recent funding of $85M, indicating a strong financial position that could lead to increased investment opportunities.

Strategic Collaborations The company has established strategic partnerships with renowned organizations like Thermo Fisher and Genentech, showcasing a commitment to collaboration and innovation. Leveraging these partnerships could open doors to new sales channels and joint ventures.

Cutting-Edge Technology Adoption Arsenal Biosciences, Inc. utilizes a modern tech stack including Ansible, Microsoft Azure, and Shopify, demonstrating a commitment to leveraging cutting-edge technologies. This technological advantage could be a selling point to attract tech-savvy clients seeking innovative solutions.

Clinical Advancements in Cell Therapy With a focus on developing programmable cell therapies for solid tumors utilizing CRISPR technology, Arsenal Biosciences, Inc. is at the forefront of clinical advancements in the field. This pioneering approach presents unique sales opportunities in the rapidly evolving biotechnology market.

Recent Funding Influx Receiving substantial funding of $70 million showcases investor confidence in Arsenal Biosciences, Inc.'s potential and growth trajectory. This influx of capital could signify expansion plans, presenting opportunities for sales professionals to target new markets and offerings.

Similar companies to Arsenal Biosciences, Inc.

Arsenal Biosciences, Inc. Tech Stack

Arsenal Biosciences, Inc. uses 8 technology products and services including Ansible, git, Shopify, and more. Explore Arsenal Biosciences, Inc.'s tech stack below.

  • Ansible
    Configuration Management
  • git
    Development
  • Shopify
    E-commerce
  • Microsoft
    Miscellaneous
  • Gatsby
    Page Builders
  • Microsoft Azure
    Platform As A Service
  • Yoast SEO
    Search Engines
  • WPMU DEV Smush
    Web Platform Extensions

Media & News

Arsenal Biosciences, Inc.'s Email Address Formats

Arsenal Biosciences, Inc. uses at least 1 format(s):
Arsenal Biosciences, Inc. Email FormatsExamplePercentage
FLast@arsenalbio.comJDoe@arsenalbio.com
89%
Last@arsenalbio.comDoe@arsenalbio.com
6%
First@arsenalbio.comJohn@arsenalbio.com
4%
FL@arsenalbio.comJD@arsenalbio.com
1%

Frequently Asked Questions

Where is Arsenal Biosciences, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Arsenal Biosciences, Inc.'s main headquarters is located at South San Francisco , CA 94080 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Arsenal Biosciences, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Arsenal Biosciences, Inc.'s official website is arsenalbio.com and has social profiles on LinkedIn.

How much revenue does Arsenal Biosciences, Inc. generate?

Minus sign iconPlus sign icon
As of September 2024, Arsenal Biosciences, Inc.'s annual revenue reached $35M.

What is Arsenal Biosciences, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Arsenal Biosciences, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Arsenal Biosciences, Inc. have currently?

Minus sign iconPlus sign icon
As of September 2024, Arsenal Biosciences, Inc. has approximately 268 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief People Officer: B. N.Chief Medical Officer: S. J.Head Of Quality Systems: R. R.. Explore Arsenal Biosciences, Inc.'s employee directory with LeadIQ.

What industry does Arsenal Biosciences, Inc. belong to?

Minus sign iconPlus sign icon
Arsenal Biosciences, Inc. operates in the Biotechnology Research industry.

What technology does Arsenal Biosciences, Inc. use?

Minus sign iconPlus sign icon
Arsenal Biosciences, Inc.'s tech stack includes AnsiblegitShopifyMicrosoftGatsbyMicrosoft AzureYoast SEOWPMU DEV Smush.

What is Arsenal Biosciences, Inc.'s email format?

Minus sign iconPlus sign icon
Arsenal Biosciences, Inc.'s email format typically follows the pattern of . Find more Arsenal Biosciences, Inc. email formats with LeadIQ.

How much funding has Arsenal Biosciences, Inc. raised to date?

Minus sign iconPlus sign icon
As of September 2024, Arsenal Biosciences, Inc. has raised $85M in funding. The last funding round occurred on Oct 17, 2019 for $85M.

When was Arsenal Biosciences, Inc. founded?

Minus sign iconPlus sign icon
Arsenal Biosciences, Inc. was founded in 2019.
Arsenal Biosciences, Inc.

Arsenal Biosciences, Inc.

Biotechnology ResearchCalifornia, United States201-500 Employees

ArsenalBiosciences, Inc., is a clinical stage programmable cell therapy company focused on the realization of solid tumor cell therapy to defeat cancer. Our discovery engine comprises precise CRISPR-enabled genome editing, integrated circuits incorporating logic gates for improved tumor targeting, and therapeutic enhancements enabling multiple pharmaceutical functions. With our programmable and computationally driven approach, we aim for enhanced and broader efficacy, increased patient safety, reduced provider costs and expanded market access. Our team is engineering living medicines to attack cancer’s inherent multi-faceted nature and bring dramatic improvements to the lives of patients. 

Section iconCompany Overview

Headquarters
South San Francisco , CA 94080 US
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
201-500

Section iconFunding & Financials

  • $85M

    Arsenal Biosciences, Inc. has raised a total of $85M of funding over 1 rounds. Their latest funding round was raised on Oct 17, 2019 in the amount of $85Mas a Series A.

  • $10M$50M

    Arsenal Biosciences, Inc.'s revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $85M

    Arsenal Biosciences, Inc. has raised a total of $85M of funding over 1 rounds. Their latest funding round was raised on Oct 17, 2019 in the amount of $85Mas a Series A.

  • $10M$50M

    Arsenal Biosciences, Inc.'s revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.